Medical Practice Valuation in Florida: A Complete Guide
- Florida medical practices typically sell for 3x–8x EBITDA depending on specialty, payor mix, and revenue quality
- Payor mix is the single biggest valuation driver — private-pay and commercial insurance practices trade at a premium over Medicare/Medicaid-heavy books
- Florida's population growth and physician shortage are creating strong buyer demand for established practices in 2025
- Reducing physician dependency and cleaning up financials 12–18 months before sale can meaningfully increase your multiple
If you own a medical practice in Florida and have ever wondered what it might be worth, the answer depends on far more than annual revenue. Buyers — whether private equity groups, hospital systems, or strategic acquirers — evaluate healthcare businesses through a multi-factor lens unique to the industry. Understanding how that valuation is constructed, and where your practice stands within it, is the first step toward a successful exit.
CBH Business Group advises healthcare and service business owners across Florida on M&A transactions ranging from $500K to $50M+. Here is what we see in the market and what it means for your practice valuation in 2025.
Why Medical Practice Valuations Are Different
Healthcare is one of the most heavily regulated industries in M&A. Unlike a landscaping company or a restaurant, a medical practice transaction involves state licensing requirements, provider credentialing, the Corporate Practice of Medicine doctrine, healthcare-specific compliance frameworks, and — in some specialties — Certificate of Need considerations. General business brokers who lack healthcare experience often miss these nuances, and sophisticated buyers know the difference immediately.
In Florida, the Corporate Practice of Medicine (CPOM) doctrine limits how non-physician entities can own and operate clinical practices. Buyers structure transactions carefully to comply with this framework, and the structure directly affects how value is allocated between goodwill, tangible assets, and employment agreements. This is one reason why working with an M&A advisor who has genuine healthcare transaction experience matters for Florida practice sellers.
At CBH Business Group, we work directly with healthcare-focused buyers and legal counsel to ensure our seller clients receive accurate valuations, navigate regulatory requirements cleanly, and close transactions efficiently. Learn more about how we work with Florida business owners.
How Medical Practices Are Valued: The Core Methods
There are three primary valuation methods used for Florida medical practices. Most transactions use all three to triangulate a realistic market value, with the final number weighted toward whichever method produces the most defensible result given the practice's profile.
1. EBITDA Multiple
Earnings Before Interest, Taxes, Depreciation, and Amortization — normalized for owner compensation, personal expenses, and one-time items — is the most widely used metric for practices generating $500K or more in annual EBITDA. Buyers apply a multiple based on specialty, scale, payor mix, and risk. A solo dermatology practice in a high-growth Florida corridor might trade at 4.5x–5.5x normalized EBITDA. A multi-site primary care group positioned as a platform acquisition could command 6x–8x if the growth story supports it.
2. Revenue Multiple
Smaller practices, or those with thin margins but strong top-line revenue, are sometimes valued on a revenue multiple — particularly in dental, ophthalmology, and primary care. Typical ranges run from 0.5x to 1.5x annual collections, depending on specialty and profitability. Revenue multiples are also used as a secondary check on EBITDA-based valuations.
3. Asset-Based Valuation
If a practice has significant equipment, real estate, or specialty infrastructure that does not translate cleanly into earnings, asset-based valuation may be used as a floor — particularly in radiology, orthopedics, and early-stage practices where goodwill has not yet been fully established.
You can use our free business valuation calculator to get a preliminary estimate based on your revenue and EBITDA before speaking with an advisor.
EBITDA Multiples by Medical Specialty in Florida
The following ranges reflect 2024–2025 market transactions in Florida and surrounding Southeast markets. Actual multiples depend on size, growth rate, payor mix, and buyer competition — these are market-rate benchmarks, not guarantees.
| Specialty | EBITDA Multiple Range | Revenue Multiple | Key Value Driver |
|---|---|---|---|
| Dermatology | 4.5x – 6.5x | 1.0x – 1.4x | Private pay and aesthetics revenue mix |
| Primary Care / Family Medicine | 3.0x – 5.0x | 0.5x – 0.9x | Panel size, value-based contracts |
| General Dentistry | 3.5x – 5.5x | 0.6x – 1.0x | New patient volume, hygiene revenue |
| Specialty Dentistry / DSO Target | 5.0x – 7.0x | 1.0x – 1.5x | EBITDA margin, multi-location growth potential |
| Behavioral Health / Mental Health | 4.0x – 6.0x | 0.7x – 1.1x | Licensed therapist capacity, payor contracts |
| Physical Therapy | 3.5x – 5.5x | 0.5x – 0.9x | Referral network depth, outcomes documentation |
| Veterinary | 5.0x – 8.0x | 1.0x – 1.6x | Revenue per visit, specialist and emergency mix |
| Ophthalmology / Eye Care | 5.0x – 7.5x | 1.0x – 1.5x | Surgical volume, optical retail add-on |
Source: CBH Business Group market analysis, Southeast U.S. healthcare M&A transaction data 2024–2025. Outliers exist in both directions based on platform potential and competitive deal dynamics.
Key Drivers That Move Your Valuation Multiple Up or Down
Understanding where buyers assign value — and where they see risk — gives you the leverage to improve your position before going to market. These are the five factors that move the needle most consistently in Florida healthcare transactions.
Payor Mix
This is the single most important variable in healthcare M&A. Practices with high private-pay or commercial insurance revenue trade at premiums. Heavy Medicare and Medicaid dependency introduces reimbursement risk and regulatory exposure that buyers discount aggressively. If your practice is 60% or more government payer, expect a substantive conversation about that at the Letter of Intent stage — and consider whether a 12–18 month initiative to shift that mix might be worth running before going to market.
Physician Dependency
If all clinical revenue flows through a single physician who is also the seller, buyers face an acute transition risk problem. Practices with associate physicians, nurse practitioners, or physician assistants generating a meaningful share of revenue are demonstrably more transferable. This mirrors the owner dependency issue in any business sale — and it is one of the most impactful things you can address before listing your practice.
Revenue Concentration
A practice that derives 35% or more of its revenue from a single employer group, hospital referral relationship, or corporate contract carries concentration risk that buyers discount. Diversified, repeatable patient volume from multiple sources is significantly more attractive and commands better pricing.
Growth Trend and Growth Story
A practice that grew 15% year-over-year for the past three years is worth more than a flat practice — even if EBITDA is identical today. Buyers pay for trajectory. If you can present a credible growth narrative — new providers being onboarded, an underserved geographic market, a service line expansion — that story carries real weight in valuation conversations.
Operational Documentation and Compliance Posture
Healthcare due diligence is among the most intensive of any industry. Buyers will review credentialing files, billing records, payer contracts, HR documentation, and compliance policies in detail. Practices with organized, current documentation close faster and at better prices. Due diligence friction — missing files, billing irregularities, unresolved compliance questions — is one of the most common reasons deals fall apart or reprice after LOI. Prepare your virtual data room before you go to market.
Florida Market Dynamics: Why 2025 Is a Strong Time to Sell
Florida is one of the most active healthcare M&A markets in the United States. Several structural forces are driving buyer demand that benefits sellers in 2025.
- Population growth: Florida added over 400,000 net new residents in 2023 alone, accelerating demand across every specialty and creating genuine scarcity value for established practices with existing patient panels
- Physician shortage: Florida consistently ranks among states with the largest physician-to-population gap, making practices with credentialed, fully staffed teams exceptionally attractive to acquirers
- Private equity consolidation: PE-backed platforms are aggressively rolling up dental, dermatology, behavioral health, veterinary, and primary care practices across Florida, creating competitive buyer dynamics that benefit sellers
- Natural succession pressure: A large cohort of Florida physicians are within 5–10 years of retirement, creating organic transaction volume and a buyer pool that is actively searching for well-positioned practices
- No state income tax: Florida's tax environment means sellers retain more of their proceeds than in most states — a meaningful factor in how owners think about timing their exit
For practice owners who have built something valuable, 2025 represents one of the more favorable seller environments of the past decade. When multiple qualified buyers are competing for the same practice, sellers have real pricing leverage. That competition is what a good M&A process is designed to create. Learn more on our business valuation page or review additional seller resources here.
How to Prepare Your Florida Medical Practice for Sale
Whether you are planning to sell in 12 months or three years, the actions you take now determine what your practice commands at exit. The practices that consistently achieve premium multiples share the following characteristics — and most of these are within your control to improve before going to market.
- Three years of clean, normalized financials: Tax returns and P&Ls that clearly distinguish personal expenses from legitimate business operations. EBITDA add-backs should be documented and defensible to a buyer's accountant.
- Associate provider coverage: At minimum 30–40% of practice revenue should be attributable to providers other than the selling physician. This is the single most impactful structural change most practice owners can make.
- Payor diversification initiative: If government payers represent more than 50% of revenue, an 18-month effort to grow commercial and private-pay revenue can move your multiple by 0.5x–1.5x.
- Organized credentialing and compliance files: Every provider's credentialing documents, payer contracts, HIPAA policies, and HR files should be current and organized. Buyers will ask for all of it.
- A documented growth narrative: Expansion opportunities, underserved patient demographics, additional service lines. Buyers pay for what a practice can become, not just what it is today.
At CBH Business Group, we work with Florida healthcare owners 12–24 months before they're ready to sell to get these elements in place. The difference between a practice that closes at 3.5x and one that closes at 5.5x is rarely the clinical quality — it is the preparation, positioning, and process.
Get a Free Broker's Opinion of Value for Your Florida Medical Practice
If you are a Florida medical practice owner thinking about your next chapter, the first step is understanding what your practice is worth in today's market. CBH Business Group offers a complimentary Broker's Opinion of Value — a complete analysis of your practice's current market value, the buyer universe most likely to compete for it, and your readiness to go to market.
There is no cost and no commitment. It is a clear-eyed, confidential assessment from advisors who work in Florida healthcare M&A every day.
Start with our free valuation calculator for a preliminary estimate, then contact us directly to schedule a confidential consultation. CBH Business Group is headquartered in St. Cloud, FL and serves healthcare and service business owners throughout Central and South Florida.
Call (407) 908-3845 or visit cbhbusinessgroup.com/contact. The right preparation, the right buyer, and the right process — that is how Florida practice owners maximize their exit.